Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study
The Moffitt Cancer Center and PatientsLikeMe.com (PLM), an online patient community, are working together to better understand the patient's entire lung cancer experience, both inside and outside the doctor's office. By combining the data that is captured by their care team in the clinic with the data participants enter at their home on PatientsLikeMe.com, the investigators hope to improve patient-physician treatment decisions, so that the patient's personal treatment goals and quality of life have the highest chances of being fulfilled.
Checked against the public recordLast updated Feb 27, 2023 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Interventions being studied
- Other: No Intervention
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * \>= 18 years of age * Diagnosed with metastatic (stage 3b/4) non-small cell lung cancer (NSCLC) * The total combined sample size must include at least 100 people who received one or more treatments of PD-1/PDL-1 inhibitor treatment (immunotherapy), and 50 patients who received an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI). Patients receiving any other treatments will be tracked for treatment outcomes, as well as to serve as comparison participants during data analyses of outcomes associated with PD-1/PDL-1 or EGFR-TKI). * Consented separately to the Total Cancer Care (TCC) protocol * Have access to the internet * Willing to enroll in the free online health tracking and patient community "PatientsLikeMe" Exclusion Criteria: * Patients enrolled in Phase I clinical trial protocols * Patients enrolled in Phase II, III or IV clinical trials involving blinded therapies (patients in open label trials will be eligible)
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- H. Lee Moffitt Cancer Center and Research InstituteTampa, Florida
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 27, 2023. Always confirm current availability with the study team.